An exciting, 'tour-de-force' paper by researchers from the Massachusetts Institute of Technology describes de novo discovery of high-affinity peptide binders for SARS-CoV-2 spike glycoprotein, which opens the door for the development of rapid viral identification or conjugates for virus-directed delivery of therapeutics.
from The Medical News https://ift.tt/36kZdDv
from The Medical News https://ift.tt/36kZdDv
Comments
Post a Comment